Galectin Therapeutics (GALT) Earnings Date, Estimates & Call Transcripts

$3.40
+0.34 (+11.11%)
(As of 03:52 PM ET)
Skip Charts & View Estimated and Actual Earnings Data

GALT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GALT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Galectin Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.16)($0.16)($0.16)
Q2 20241($0.16)($0.16)($0.16)
Q3 20241($0.17)($0.17)($0.17)
Q4 20241($0.17)($0.17)($0.17)
FY 20244($0.66)($0.66)($0.66)

GALT Earnings Date and Information

Galectin Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.

Galectin Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/20/2024
Estimated)
------- 
11/13/2023Q3 2023($0.16)($0.24)($0.08)($0.24)--
8/14/2023Q2 2023($0.21)($0.15)+$0.06($0.15)--
5/15/2023Q1 2023($0.21)($0.19)+$0.02($0.19)--
3/30/2023Q4 2022($0.17)($0.18)($0.01)($0.18)--
11/14/2022Q3 2022($0.20)($0.14)+$0.06($0.14)--
8/15/2022Q2 2022($0.19)($0.16)+$0.03($0.16)--
5/16/2022Q1 2022($0.10)($0.17)($0.07)($0.17)--
3/31/2022Q4 2021-($0.13)($0.13)($0.14)--
11/15/2021Q3 2021($0.18)($0.14)+$0.04($0.14)--
8/16/2021Q2 2021($0.18)($0.15)+$0.03($0.15)--
5/16/2021Q1 2021($0.17)($0.11)+$0.06($0.11)--

Galectin Therapeutics Earnings - Frequently Asked Questions

When is Galectin Therapeutics's earnings date?

Galectin Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on GALT's earnings history.

How much profit does Galectin Therapeutics generate each year?

Galectin Therapeutics (NASDAQ:GALT) has a recorded net income of -$41.07 million. GALT has generated -$0.74 earnings per share over the last four quarters.

What is Galectin Therapeutics's EPS forecast for next year?

Galectin Therapeutics's earnings are expected to decrease from ($0.66) per share to ($1.59) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:GALT) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners